Six-Week Hospital-Based Pulmonary Rehabilitation in Covid Pneumonia ICU Survivors: Experience from a Tertiary Care Center in Central India
- PMID: 35404239
- PMCID: PMC9449983
- DOI: 10.5152/TurkThoracJ.2022.21159
Six-Week Hospital-Based Pulmonary Rehabilitation in Covid Pneumonia ICU Survivors: Experience from a Tertiary Care Center in Central India
Abstract
Objective: There is very limited data on the usefulness of pulmonary rehabilitation in patients with coronavirus pneumonia who have survived intensive care unit care. The primary aim was to explore the feasibility of conducting a pulmonary rehabilitation program in patients with coronavirus disease-19 pneumonia surviving intensive care. The secondary aim was to study the impact of a hospital-based 6-week pulmonary rehabilitation program on exercise capacity, quality of life, and psychological parameters in these patients. This study was conducted at the Center for Pulmonary Rehabilitation, Department of Pulmonary Medicine of the institute.
Material and methods: A total of 27 patients were enrolled. Among them, 14 patients who completed the desired 12 sessions over 6 weeks constituted the pulmonary rehabilitation group and 13 patients who either did not consent or defaulted within the first 2 weeks were considered as controls. Both groups had assessments at 0 and 6 weeks that included a 6-Minute Walk Test, Incremental Shuttle Walk Test, mMRC Dyspnea Scale, Baseline Dyspnea Index, and Transitional Dyspnea Index, Saint George's Respiratory Questionnaire score, and Depression, Anxiety, Stress Scale-21 score.
Results: Significant improvement in dyspnea by mMRC (P = .01) and exercise capacity as measured by 6-Minute Walk Test (P <.001) and Incremental Shuttle Walk Test (P = .025) was seen in the pulmonary rehabilitation group as compared to the control group. There was no significant improvement in quality of life and psychological parameters (Depression, Anxiety, Stress Scale 21 score) after 6 weeks of pulmonary rehabilitation program as measured in our study.
Conclusion: Pulmonary rehabilitation is feasible and appears promising in coronavirus disease acute respiratory distress syndrome survivors. However, data from other centers and a larger number of patients are required to imbibe conclusive results.
Figures


Similar articles
-
Long-Term Benefits of Pulmonary Rehabilitation in Patients With COPD: A 2-Year Follow-Up Study.Chest. 2021 Mar;159(3):967-974. doi: 10.1016/j.chest.2020.10.032. Epub 2020 Oct 22. Chest. 2021. PMID: 33098829
-
The effectiveness of pulmonary rehabilitation on chronic obstructive pulmonary disease patients with concurrent presence of comorbid depression and anxiety.Respir Med. 2022 Jun;197:106850. doi: 10.1016/j.rmed.2022.106850. Epub 2022 Apr 9. Respir Med. 2022. PMID: 35427843
-
Therapeutic respiratory and functional rehabilitation protocol for intensive care unit patients affected by COVID-19: a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Apr 12;22(1):268. doi: 10.1186/s13063-021-05210-y. Trials. 2021. PMID: 33845878 Free PMC article.
-
The Short- and Long-Term Impact of Pulmonary Rehabilitation in Subjects with Sarcoidosis: A Prospective Study and Review of the Literature.Respiration. 2021;100(5):423-431. doi: 10.1159/000514917. Epub 2021 Mar 30. Respiration. 2021. PMID: 33784708 Review.
-
Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19).Chronic Dis Transl Med. 2020 May 14;6(2):79-86. doi: 10.1016/j.cdtm.2020.05.002. eCollection 2020 Jun. Chronic Dis Transl Med. 2020. PMID: 32411496 Free PMC article. Review.
Cited by
-
The heart and SARS-CoV-2.Med Clin (Engl Ed). 2022 Nov 11;159(9):440-446. doi: 10.1016/j.medcle.2022.10.001. Epub 2022 Oct 14. Med Clin (Engl Ed). 2022. PMID: 36268184 Free PMC article. Review.
-
The heart and SARS-CoV-2.Med Clin (Barc). 2022 Nov 11;159(9):440-446. doi: 10.1016/j.medcli.2022.07.002. Epub 2022 Jul 20. Med Clin (Barc). 2022. PMID: 35945062 Free PMC article. Review. English, Spanish.
-
Effects of pulmonary rehabilitation on respiratory function in mechanically ventilated patients: a systematic review and meta-analysis.BMC Pulm Med. 2025 Jan 3;25(1):4. doi: 10.1186/s12890-024-03461-4. BMC Pulm Med. 2025. PMID: 39754074 Free PMC article.
References
-
- World Health Organization. Clinical Management of COVID-19. WHO; Geneva; 2019. WHO/2019-nCoV/clinical/2020.2015.
-
- World Health Organization. Available at: https://covid19.who.int/.
LinkOut - more resources
Full Text Sources